PIDTC: Exploring Factors Affecting Survival of Individuals with Severe Combined Immunodeficiency
14 de ago. de 2023 ·
1m 48s
Descarga y escucha en cualquier lugar
Descarga tus episodios favoritos y disfrútalos, ¡dondequiera que estés! Regístrate o inicia sesión ahora para acceder a la escucha sin conexión.
Descripción
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in The Lancet on June 20, 2023, titled "Measuring the effect of...
mostra más
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in The Lancet on June 20, 2023, titled "Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium."
Read the paper here: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00731-6/fulltext
Learn more about PIDTC: https://pidtc.rarediseasesnetwork.org
mostra menos
Read the paper here: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00731-6/fulltext
Learn more about PIDTC: https://pidtc.rarediseasesnetwork.org
Información
| Autor | RDCRN |
| Página web | - |
| Etiquetas |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
